StonvexLoading…
StonvexStonvexStonvexCore line items from RIVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.38B | $5.39B | $4.10B | $2.54B |
Operating Income | $-881.00M | $-3.58B | $-2.75B | $-1.77B |
Net Income | $-416.00M | $-3.65B | $-2.83B | $-1.66B |
EPS (Diluted) | $-0.33 | $-3.07 | $-2.42 | $-1.45 |
Total Assets | $14.23B | $14.86B | $15.22B | $15.60B |
Total Liabilities | $9.80B | $10.27B | $10.13B | $9.52B |
Cash & Equivalents | $2.85B | $3.58B | $4.44B | $4.81B |
Free Cash Flow OCF − CapEx | $-1.07B | $-2.49B | $-1.34B | $-924.00M |
Shares Outstanding | 1.26B | 1.24B | 1.23B | 1.21B |